BioAlliance has signed a co-promotion agreement with Lundbeck for Seroplex antidepressant. Reportedly, the company would co-promote Seroplex to its core healthcare partners, as part of a comprehensive approach
Dr Reddy’s Laboratories has announced its unaudited financial results for the first quarter ended June, 2009. The company has reported an overall revenues of $381 million in Q1
Idaho Technology is a privately held biotechnology company based in Salt Lake City, Utah.
Lexicon has received orphan drug designation from the European Medicines Agency (EMEA) for LX1032. It is intended for managing gastrointestinal symptoms associated with carcinoid syndrome. LX1032 is
Oramed Pharmaceuticals has reported positive results from a phase 2A study of oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The study evaluated safety, tolerability and food
CytoDyn has completed safety testing of Cytolin. Its an immune-system modulator for managing HIV disease and the public health crisis, afflicting communities where the infection is spreading due
Poniard has reported the results of phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent. The study evaluated the cardiac safety of picoplatin by
FoldRx has reported positive results from its pivotal phase II/III clinical study of ttafamidis (Fx-1006A), in patients suffering from TTR amyloid polyneuropathy (ATTR-PN). Its a fatal orphan disease
Actelion has posted its financial results for the first half of 2009. The company posts total net revenues of CHF855.2 million, an increase of 27% for the first
Premier Insurance Management Services (PIMS) has announced a new professional medical liability insurance program. The program offers risk management and hospital medical malpractice protection to not-for-profit hospital members
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.